Featured Opening Session Speakers

Los Alamos National Laboratory
BERNARD FIELDS LECTURE

CDC Kenya
N’GALY-MANN LECTURE

Advocacy for Prevention of HIV and AIDS
MARTIN DELANEY PRESENTATION

NIAID
SPECIAL RECOGNITION
AND PERSONAL PERSPECTIVES

The 30th Conference on Retroviruses and Opportunistic Infections (CROI), held from February 19 to 22, 2023, is planned as an in-person conference at the new Summit Convention Center in Seattle, Washington. The best and most consequential original research on HIV and related conditions will define the science at the conference. CROI 2023 will also accept important new findings on SARS-CoV-2 and the monkeypox virus. The in-person conference will also feature innovative interactive sessions, rich poster sessions, and networking opportunities.

The CROI 2023 Program below is preliminary and subject to change. New information will be posted as it becomes available.

8:30 AM PT - 12:30 PM PT
SCOTT M. HAMMER WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES

Widely considered the most informative and comprehensive session, this workshop highlights key presentations that will take place during CROI. Although the workshop is directed toward new investigators and trainees (eg, undergraduate students, graduate students, postdoctoral fellows, and physician fellows), all CROI attendees are encouraged to attend. Scholarship recipients are required to attend.

Moderators: Nicolas Chomont, Université de Montréal, and Serena S. Spudich, Yale University
  • ADVANCES IN MOLECULAR VIROLOGY OF HIV AND SARS-CoV-2
    Stuart Neil
  • ADVANCES IN HIV AND SARS-CoV-2 IMMUNOLOGY
    Guido Silvestri
  • COMMUNITY PERSPECTIVE
    Dawn Averitt
  • ADVANCES IN HIV TREATMENT STRATEGIES
    Monica Gandhi
  • ADVANCES IN BIOMEDICAL PREVENTION OF HIV
    Raphael Landovitz
  • ADVANCES IN HIV CURE
    John Mellors
1:30 PM PT - 3:30 PM PT
CONCURRENT TECHNICAL WORKSHOPS

FRONTIERS IN LABORATORY TECHNOLOGIES

Moderators: Frank Kirchhoff and Katharine Bar
  • SINGLE-CELL MULTIOMIC ANALYSES OF THE HIV RESERVOIR
    Michael Betts
  • SINGLE-CELL GLYCOMICS ANALYSIS BY CyTOF-Lec
    Nadia Roan
  • SINGLE-CELL ANALYSES OF THE RESERVOIR
    Ya-Chi Ho
  • PROTEIN DYNAMICS BY Cryo-EM: NOVEL APPROACHES TO CHARACTERIZING IMMUNE RECOGNITION
    Michael Birnbaum

CASE-BASED LIVER WORKSHOP

Moderators: Debika Bhattacharya and Christoph Boesecke
  • FULMINANT HEPATITIS IN CHILDREN
    Luz Helena Gutierrez Sanchez
  • HBV PREVENTION
    H. Nina Kim
  • HEPATITIS DELTA INFECTION AMONG PERSONS LIVING WITH HIV
    Charles Béguelin

CLINICAL TRIAL DESIGN AND ANALYSIS

Moderators: Susan Buchbinder and Richard Chaisson
  • WHAT HAVE WE LEARNED FROM PLATFORM TRIALS?
    Michael Hughes
  • UNPACKING MODELING STUDIES
    Viviane Lima
  • INCLUSION OF SOCIAL AND BEHAVIORAL SCIENCE IN CLINICAL TRIALS
    Heidi van Rooyen
5:00 PT - 7:00 PM PT
OPENING SESSION

BERNARD FIELDS LECTURE

Alan S. Perelson, Los Alamos National Laboratory, Los Alamos, NM, USA

The Bernard Fields Lecture recognizes a basic scientist for important and relevant contributions to the fields of virology and viral pathogenesis.

N’GALY-MANN LECTURE

Kevin M. De Cock, Centers for Disease Control and Prevention (CDC) Mission in Kenya (former), Nairobi, Kenya

The N’Galy-Mann Lecture recognizes an HIV/AIDS researcher for important and relevant work in the fields of epidemiology or clinical research.

MARTIN DELANEY PRESENTATION

Yvette Raphael, Advocacy for Prevention of HIV and AIDS, South Africa

The Martin Delaney Presentation recognizes the important contributions of community advocacy and engagement to HIV/AIDS research.

ACKNOWLEDGING THE 30TH CROI

Commentaries from HIV research, care, policy, and advocacy leaders look back at past advances through the lens of CROI and forward toward future challenges.

SPECIAL RECOGNITION OF DR ANTHONY FAUCI

We take the opportunity of the 30th CROI to honor Dr Athony S. Fauci. Dr Fauci will offer personal perspectives from his 40+ years of conducting and overseeing HIV-related science since the start of the AIDS pandemic. The milestones, the lessons learned, the most exciting moments, and how he sees the challenges and opportunities for the next generation of HIV/AIDS scientists.

8:30 AM PT - 9:30 AM PT
MONDAY PLENARY SESSION

20 YEARS OF PEPFAR: LOOKING BACK, STRIDING FORWARD

John Nkengasong, US Department of State, Washington, DC, USA

 

THE PATH TO HEPATITIS B CURE

Anna Suk-Fong Lok, University of Michigan Medical School, Ann Arbor, MI, USA

10:00 AM PT - 12:00 PM PT
CONCURRENT ORAL ABSTRACT SESSIONS

Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.

  • VIROLOGY/PATHOGENESIS
  • TB AND HEPATITIS
  • HIV AND STI PREVENTION: NEW TOOLS AND APPROACHES
  • INSIGHTS INTO PREVENTION AND TREATMENT OF HIV IN WOMEN AND CHILDREN
12:00 PM PT - 1:30 PM PT
Lunch Break for Attendees and New Investigator Networking Sessions
1:30 PM PT - 2:30 PM PT
CONCURRENT THEMED DISCUSSIONS

Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.

2:30 PM PT - 4:00 PM PT
POSTER SESSIONS

Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in-person will be assigned to stand at their respective boards, organized by topic, on one of the three conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).

4:00 PM PT - 5:30 PM PT
CONCURRENT INTERACTIVE SYMPOSIA

VIRAL EVOLUTION OF HIV AND SARS-CoV-2

Moderators: Theodora Hatziioannou and Julie Overbaugh 
  • ORIGINS OF HIV-1 AND SARS-CoV-2
    Michael Worobey
  • POPULATION-LEVEL EVOLUTION OF HIV-1 AND SARS-CoV-2
    Tulio de Oliveira
  • GLOBAL SURVEILLANCE OF HIV-1 AND SARS-CoV-2
    Emma Hodcroft

FROM ROCKET SCIENCE TO REALITY: MONITORING ANTIRETROVIRALS AND ADHERENCE

Moderators: K. Rivet Amico and Alice Tseng
  • THE LANDSCAPE OF ADHERENCE TESTING
    Peter Anderson
  • DIGITAL TECHNOLOGIES FOR SUPPORTING ADHERENCE
    Lisa Hightow-Weidman
  • MEASURING ADHERENCE WITH LA/ED THERAPIES IN LOW AND MIDDLE INCOME COUNTRIES
    Mohammed Lamorde

DELIVERING ON THE SUCCESS OF INJECTABLE PrEP

Moderators: Saiqa Mullick and Christina Psaros
  • FROM EFFICACY TO EFFECTIVENESS
    Nyaradzo Mgodi
  • AVOIDING DISPARITIES: NOT MAKING THE SAME MISTAKE AGAIN
    LaRon Nelson
  • DATA GAPS FOR POPULATIONS LEFT BEHIND
    Sunil Solomon
8:30 AM PT - 9:30 AM PT
TUESDAY PLENARY SESSION

HIV RESERVOIRS: OBSTACLES TO A CURE

Janet Siliciano, Johns Hopkins University School of Medicine, Baltimore, MD, USA

 

RESTRICTIONS ON REPRODUCTIVE RIGHTS AND THEIR IMPACT ON PEOPLE LIVING WITH HIV

Denise J. Jamieson, Emory University School of Medicine, Atlanta, GA, USA

10:00 AM PT - 12:00 PM PT
CONCURRENT ORAL ABSTRACT SESSIONS

Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.

  • HIV RESERVIORS AND CURE STRATEGIES
  • CONSTERNATION ABOUT COMPLICATIONS
  • GLOBAL EPIDEMIOLOGY OF HIV
  • ALL MODES LEAD TO PrEP
12:00 PM PT - 1:30 PM PT
Lunch Break for Attendees and New Investigator Networking Sessions
1:30 PM PT - 2:30 PM PT
CONCURRENT THEMED DISCUSSIONS

Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.

2:30 PM PT - 4:00 PM PT
POSTER SESSIONS

Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in-person will be assigned to stand at their respective boards, organized by topic, on one of the three conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).

4:00 PM PT - 5:30 PM PT
CONCURRENT INTERACTIVE SYMPOSIA

PEDIATRIC CURE

 Moderator: Deborah Persaud
  • APPROACHES TO PEDIATRIC CURE
    Philip Goulder
  • NHP STUDIES OF PEDIATRIC CURE MECHANISMS AND INTERVENTIONS
    Ann Chahroudi
  • PROGRESS IN CLINICAL TRIALS OF HIV PREVENTION AND CURE
    Roger Shapiro

CASE-BASED DISCUSSION ON COVID-19: WHERE ARE WE NOW?

 

GETTING PrEPped (AND PEPped) FOR SEX: FROM HIV TO STIs TO MONKEYPOX

Moderators: Bridget Haire and Maryam Shamanesh
  • IMPLEMENTING THE PrEP AND PEP TOOLKIT
    Colleen Kelley
  • PREVENTION OF STIs IN ADULTS AND ADOLESCENTS
    James Kiarie
  • PREVENTING MONKEYPOX
    Jade Ghosn
8:30 AM PT - 9:30 AM PT
WEDNESDAY PLENARY SESSION

IDENTIFYING HIV VIRUS-HOST INTERACTIONS: IMPORTANT FOR VIRAL PATHOGENESIS

Paul Lehner, University of Cambridge, Cambridge, United Kingdom

 

THE SCIENCE OF AGING: LESSONS FOR HIV

George Kuchel, University of Connecticut Health Center, Farmington, CT, USA

10:00 AM PT - 12:00 PM PT
CONCURRENT ORAL ABSTRACT SESSIONS

Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.

  • IMMUNOPATHOGENESIS AND VACCINES
  • NEUROPATHOGENESIS AND NEUROLOGIC COMPLICATIONS OF HIV AND SARS-COV-2
  • ANTIVIRAL STRATEGIES FOR TREATMENT AND PREVENTIONS
  • OPTIMIZING THE HIV TREATMENT CASCADE
12:00 PM PT - 1:30 PM PT
Lunch Break for Attendees and New Investigator Networking Sessions
12:15 PM PT - 1:15 PM PT
Special Session on the Monkeypox Virus Outbreak
1:30 PM PT - 2:30 PM PT
CONCURRENT THEMED DISCUSSIONS

Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.

2:30 PM PT - 4:00 PM PT
POSTER SESSIONS

Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in-person will be assigned to stand at their respective boards, organized by topic, on one of the three conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).

4:00 PM PT - 5:30 PM PT
CONCURRENT INTERACTIVE SYMPOSIA

THE VIRUSES THEY ARE A CHANGING: HOW THE IMMUNE SYSTEM RESPONDS

 Moderators: Wendy Barclay and George Lewis
  • EPITOPE MASKING DURING A RECALL RESPONSE: IMPLICATIONS FOR COVID AND HIV VACCINES
    Facundo Batista
  • MEMORY B CELL RESPONSES TO NEW VIRUS VARIANTS: RELEVANCE TO THE CONCEPT OF ORIGINAL ANTIGENIC SIN
    Marion Pepper
  • EFFECT OF NEW VIRAL VARIANTS ON NEUTRALIZING ANTIBODY POTENCY AND BREADTH
    Penny Moore

CASE-BASED DISCUSSION OF CARDIO-METABOLIC COMPLICATIONS OF HIV AND CONSEQUENCES FOR MANAGEMENT

Moderators: Georg Behrens and Vidya Mave
  • CASE 1: CARDIOVASCULAR DISEASE
    Pam Douglas and Ntobeko Ntsui 
  • CASE 2: WEIGHT GAIN, OBSESITY
    Donal O’Shea
  • CASE 3: NONALCOHOLIC STEATOHEPATITIS/NONALCOHOLIC FATTY LIVER DISEASE
    Giada Sebastiani

SCIENCE COMMUNICATION IN THE AGE OF MISINFORMATION

Moderators: Jonathan Mermin and Jon Cohen
  • USE AND MISUSE OF SOCIAL AND OTHER MEDIA AND ITS INFLUENCE ON HEALTH AND BEHAVIOR
    Emily Vraga
  • USE AND MISUSE OF SOCIAL AND OTHER MEDIA AND ITS INFLUENCE ON HEALTH AND BEHAVIOR
    Scott Ratzan
  • VACCINE HESITANCY AND MISINFORMATION
    Heidi Larson
Sunday, February 19, 2023
8:30 AM PT - 12:30 PM PT
SCOTT M. HAMMER WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES

Widely considered the most informative and comprehensive session, this workshop highlights key presentations that will take place during CROI. Although the workshop is directed toward new investigators and trainees (eg, undergraduate students, graduate students, postdoctoral fellows, and physician fellows), all CROI attendees are encouraged to attend. Scholarship recipients are required to attend.

Moderators: Nicolas Chomont, Université de Montréal, and Serena S. Spudich, Yale University
  • ADVANCES IN MOLECULAR VIROLOGY OF HIV AND SARS-CoV-2
    Stuart Neil
  • ADVANCES IN HIV AND SARS-CoV-2 IMMUNOLOGY
    Guido Silvestri
  • COMMUNITY PERSPECTIVE
    Dawn Averitt
  • ADVANCES IN HIV TREATMENT STRATEGIES
    Monica Gandhi
  • ADVANCES IN BIOMEDICAL PREVENTION OF HIV
    Raphael Landovitz
  • ADVANCES IN HIV CURE
    John Mellors
1:30 PM PT - 3:30 PM PT
CONCURRENT TECHNICAL WORKSHOPS

FRONTIERS IN LABORATORY TECHNOLOGIES

Moderators: Frank Kirchhoff and Katharine Bar
  • SINGLE-CELL MULTIOMIC ANALYSES OF THE HIV RESERVOIR
    Michael Betts
  • SINGLE-CELL GLYCOMICS ANALYSIS BY CyTOF-Lec
    Nadia Roan
  • SINGLE-CELL ANALYSES OF THE RESERVOIR
    Ya-Chi Ho
  • PROTEIN DYNAMICS BY Cryo-EM: NOVEL APPROACHES TO CHARACTERIZING IMMUNE RECOGNITION
    Michael Birnbaum

CASE-BASED LIVER WORKSHOP

Moderators: Debika Bhattacharya and Christoph Boesecke
  • FULMINANT HEPATITIS IN CHILDREN
    Luz Helena Gutierrez Sanchez
  • HBV PREVENTION
    H. Nina Kim
  • HEPATITIS DELTA INFECTION AMONG PERSONS LIVING WITH HIV
    Charles Béguelin

CLINICAL TRIAL DESIGN AND ANALYSIS

Moderators: Susan Buchbinder and Richard Chaisson
  • WHAT HAVE WE LEARNED FROM PLATFORM TRIALS?
    Michael Hughes
  • UNPACKING MODELING STUDIES
    Viviane Lima
  • INCLUSION OF SOCIAL AND BEHAVIORAL SCIENCE IN CLINICAL TRIALS
    Heidi van Rooyen
5:00 PT - 7:00 PM PT
OPENING SESSION

BERNARD FIELDS LECTURE

Alan S. Perelson, Los Alamos National Laboratory, Los Alamos, NM, USA

The Bernard Fields Lecture recognizes a basic scientist for important and relevant contributions to the fields of virology and viral pathogenesis.

N’GALY-MANN LECTURE

Kevin M. De Cock, Centers for Disease Control and Prevention (CDC) Mission in Kenya (former), Nairobi, Kenya

The N’Galy-Mann Lecture recognizes an HIV/AIDS researcher for important and relevant work in the fields of epidemiology or clinical research.

MARTIN DELANEY PRESENTATION

Yvette Raphael, Advocacy for Prevention of HIV and AIDS, South Africa

The Martin Delaney Presentation recognizes the important contributions of community advocacy and engagement to HIV/AIDS research.

ACKNOWLEDGING THE 30TH CROI

Commentaries from HIV research, care, policy, and advocacy leaders look back at past advances through the lens of CROI and forward toward future challenges.

SPECIAL RECOGNITION OF DR ANTHONY FAUCI

We take the opportunity of the 30th CROI to honor Dr Athony S. Fauci. Dr Fauci will offer personal perspectives from his 40+ years of conducting and overseeing HIV-related science since the start of the AIDS pandemic. The milestones, the lessons learned, the most exciting moments, and how he sees the challenges and opportunities for the next generation of HIV/AIDS scientists.

Monday, February 20, 2023
8:30 AM PT - 9:30 AM PT
MONDAY PLENARY SESSION

20 YEARS OF PEPFAR: LOOKING BACK, STRIDING FORWARD

John Nkengasong, US Department of State, Washington, DC, USA

 

THE PATH TO HEPATITIS B CURE

Anna Suk-Fong Lok, University of Michigan Medical School, Ann Arbor, MI, USA

10:00 AM PT - 12:00 PM PT
CONCURRENT ORAL ABSTRACT SESSIONS

Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.

  • VIROLOGY/PATHOGENESIS
  • TB AND HEPATITIS
  • HIV AND STI PREVENTION: NEW TOOLS AND APPROACHES
  • INSIGHTS INTO PREVENTION AND TREATMENT OF HIV IN WOMEN AND CHILDREN
12:00 PM PT - 1:30 PM PT
Lunch Break for Attendees and New Investigator Networking Sessions
1:30 PM PT - 2:30 PM PT
CONCURRENT THEMED DISCUSSIONS

Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.

2:30 PM PT - 4:00 PM PT
POSTER SESSIONS

Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in-person will be assigned to stand at their respective boards, organized by topic, on one of the three conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).

4:00 PM PT - 5:30 PM PT
CONCURRENT INTERACTIVE SYMPOSIA

VIRAL EVOLUTION OF HIV AND SARS-CoV-2

Moderators: Theodora Hatziioannou and Julie Overbaugh 
  • ORIGINS OF HIV-1 AND SARS-CoV-2
    Michael Worobey
  • POPULATION-LEVEL EVOLUTION OF HIV-1 AND SARS-CoV-2
    Tulio de Oliveira
  • GLOBAL SURVEILLANCE OF HIV-1 AND SARS-CoV-2
    Emma Hodcroft

FROM ROCKET SCIENCE TO REALITY: MONITORING ANTIRETROVIRALS AND ADHERENCE

Moderators: K. Rivet Amico and Alice Tseng
  • THE LANDSCAPE OF ADHERENCE TESTING
    Peter Anderson
  • DIGITAL TECHNOLOGIES FOR SUPPORTING ADHERENCE
    Lisa Hightow-Weidman
  • MEASURING ADHERENCE WITH LA/ED THERAPIES IN LOW AND MIDDLE INCOME COUNTRIES
    Mohammed Lamorde

DELIVERING ON THE SUCCESS OF INJECTABLE PrEP

Moderators: Saiqa Mullick and Christina Psaros
  • FROM EFFICACY TO EFFECTIVENESS
    Nyaradzo Mgodi
  • AVOIDING DISPARITIES: NOT MAKING THE SAME MISTAKE AGAIN
    LaRon Nelson
  • DATA GAPS FOR POPULATIONS LEFT BEHIND
    Sunil Solomon
Tuesday, February 21, 2023
8:30 AM PT - 9:30 AM PT
TUESDAY PLENARY SESSION

HIV RESERVOIRS: OBSTACLES TO A CURE

Janet Siliciano, Johns Hopkins University School of Medicine, Baltimore, MD, USA

 

RESTRICTIONS ON REPRODUCTIVE RIGHTS AND THEIR IMPACT ON PEOPLE LIVING WITH HIV

Denise J. Jamieson, Emory University School of Medicine, Atlanta, GA, USA

10:00 AM PT - 12:00 PM PT
CONCURRENT ORAL ABSTRACT SESSIONS

Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.

  • HIV RESERVIORS AND CURE STRATEGIES
  • CONSTERNATION ABOUT COMPLICATIONS
  • GLOBAL EPIDEMIOLOGY OF HIV
  • ALL MODES LEAD TO PrEP
12:00 PM PT - 1:30 PM PT
Lunch Break for Attendees and New Investigator Networking Sessions
1:30 PM PT - 2:30 PM PT
CONCURRENT THEMED DISCUSSIONS

Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.

2:30 PM PT - 4:00 PM PT
POSTER SESSIONS

Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in-person will be assigned to stand at their respective boards, organized by topic, on one of the three conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).

4:00 PM PT - 5:30 PM PT
CONCURRENT INTERACTIVE SYMPOSIA

PEDIATRIC CURE

 Moderator: Deborah Persaud
  • APPROACHES TO PEDIATRIC CURE
    Philip Goulder
  • NHP STUDIES OF PEDIATRIC CURE MECHANISMS AND INTERVENTIONS
    Ann Chahroudi
  • PROGRESS IN CLINICAL TRIALS OF HIV PREVENTION AND CURE
    Roger Shapiro

CASE-BASED DISCUSSION ON COVID-19: WHERE ARE WE NOW?

 

GETTING PrEPped (AND PEPped) FOR SEX: FROM HIV TO STIs TO MONKEYPOX

Moderators: Bridget Haire and Maryam Shamanesh
  • IMPLEMENTING THE PrEP AND PEP TOOLKIT
    Colleen Kelley
  • PREVENTION OF STIs IN ADULTS AND ADOLESCENTS
    James Kiarie
  • PREVENTING MONKEYPOX
    Jade Ghosn
Wednesday, February 22, 2023
8:30 AM PT - 9:30 AM PT
WEDNESDAY PLENARY SESSION

IDENTIFYING HIV VIRUS-HOST INTERACTIONS: IMPORTANT FOR VIRAL PATHOGENESIS

Paul Lehner, University of Cambridge, Cambridge, United Kingdom

 

THE SCIENCE OF AGING: LESSONS FOR HIV

George Kuchel, University of Connecticut Health Center, Farmington, CT, USA

10:00 AM PT - 12:00 PM PT
CONCURRENT ORAL ABSTRACT SESSIONS

Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.

  • IMMUNOPATHOGENESIS AND VACCINES
  • NEUROPATHOGENESIS AND NEUROLOGIC COMPLICATIONS OF HIV AND SARS-COV-2
  • ANTIVIRAL STRATEGIES FOR TREATMENT AND PREVENTIONS
  • OPTIMIZING THE HIV TREATMENT CASCADE
12:00 PM PT - 1:30 PM PT
Lunch Break for Attendees and New Investigator Networking Sessions
12:15 PM PT - 1:15 PM PT
Special Session on the Monkeypox Virus Outbreak
1:30 PM PT - 2:30 PM PT
CONCURRENT THEMED DISCUSSIONS

Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.

2:30 PM PT - 4:00 PM PT
POSTER SESSIONS

Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in-person will be assigned to stand at their respective boards, organized by topic, on one of the three conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).

4:00 PM PT - 5:30 PM PT
CONCURRENT INTERACTIVE SYMPOSIA

THE VIRUSES THEY ARE A CHANGING: HOW THE IMMUNE SYSTEM RESPONDS

 Moderators: Wendy Barclay and George Lewis
  • EPITOPE MASKING DURING A RECALL RESPONSE: IMPLICATIONS FOR COVID AND HIV VACCINES
    Facundo Batista
  • MEMORY B CELL RESPONSES TO NEW VIRUS VARIANTS: RELEVANCE TO THE CONCEPT OF ORIGINAL ANTIGENIC SIN
    Marion Pepper
  • EFFECT OF NEW VIRAL VARIANTS ON NEUTRALIZING ANTIBODY POTENCY AND BREADTH
    Penny Moore

CASE-BASED DISCUSSION OF CARDIO-METABOLIC COMPLICATIONS OF HIV AND CONSEQUENCES FOR MANAGEMENT

Moderators: Georg Behrens and Vidya Mave
  • CASE 1: CARDIOVASCULAR DISEASE
    Pam Douglas and Ntobeko Ntsui 
  • CASE 2: WEIGHT GAIN, OBSESITY
    Donal O’Shea
  • CASE 3: NONALCOHOLIC STEATOHEPATITIS/NONALCOHOLIC FATTY LIVER DISEASE
    Giada Sebastiani

SCIENCE COMMUNICATION IN THE AGE OF MISINFORMATION

Moderators: Jonathan Mermin and Jon Cohen
  • USE AND MISUSE OF SOCIAL AND OTHER MEDIA AND ITS INFLUENCE ON HEALTH AND BEHAVIOR
    Emily Vraga
  • USE AND MISUSE OF SOCIAL AND OTHER MEDIA AND ITS INFLUENCE ON HEALTH AND BEHAVIOR
    Scott Ratzan
  • VACCINE HESITANCY AND MISINFORMATION
    Heidi Larson